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Prior experiments have demonstrated that IL-16 interferes with antigen recognition and Th2 cytokine production by CD4ϩ cells. We tested the hypothesis that IL-16 down-regulates Th2-mediated immune responses in the murine ovalbumin sensitization and challenge model. T cells isolated from ovalbumin-sensitized mice that had been treated systemically with IL-16 had markedly diminished antigen-induced IL-5 release (Fig 1) . IL-16 had a similarly inhibitory effect on the response to aerosol allergen challenge. There was lower BAL eosinophilia (mean 14 ϫ 10 3 vs 163 ϫ 10 3 per sample) and airway inflammation from mice treated intratracheally with IL-16 prior to each ovalbumin challenge. In order to correlate physiologic with inflammatory responses, we measured airway reactivity to methacholine in ovalbumin-sensitized and challenged mice treated with IL-16 or vehicle. Ovalbumin-induced airway hyperresponsiveness (AHR) was diminished by intratracheal IL-16 treatment (Fig 2) . These results were corroborated with the finding of augmented AHR in ovalbumin-sensitized and challenged IL-16 knockout mice compared to wt littermate control mice.
We conclude that there are corresponding immunomodulatory effects of IL-16 on allergic airway inflammation in vivo to those seen on CD4ϩ T cells in vitro. These observations suggest that IL-16 and related compounds may offer a novel therapeutic approach to allergic airway inflammation and AHR seen in asthma. T he goal of this study was to determine whether sensations of dyspnea would change when inspiratory resistive loads were applied on several consecutive days in healthy subjects. We hypothesized that learning occurs with repetitions of inspiratory loading and would cause dyspnea to attenuate with repeated exposure to the same load.
Learning Occurs With Repetitions of Inspiratory
We recruited four study groups, each with five subjects. All subjects underwent normal spirometry. Subjects breathed through a snugly fit facemask, and a one-way valve separated inspiratory and expiratory airflow. Airflow, frequency, and volume were measured continuously. Each *From the University of Medicine and Dentistry of New Jersey, Newark, NJ. This study was made possible by a grant from the American Lung Association/New Jersey Thoracic Society. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (e-mail: permissions@chestnet.org). Correspondence to: Stasia Jastrzembski-Wieber, MD, FCCP, 150 Bergen St, UHI354, Newark, NJ 07103; session consisted of 90 min. For the first 30 min, the subjects breathed with no inspiratory load present. In the last 60 min, the load varied according to group assignment: group 1, no inspiratory load; group 2, low inspiratory load (1.3 cm H 2 O/L/s); or group 3, medium inspiratory load (3.4 cm H 2 O/L/s); or group 4, heavy inspiratory load (14.1 cm H 2 O/L/s). Trials were repeated on 3 consecutive days for the first three groups and for 4 days for the fourth group. Borg scores were obtained at the beginning and the end of the first 30 min, and at the beginning of loaded breathing and every 30 min thereafter. Anxiety was measured using the State-Trait Anxiety Inventory.
We found that dyspnea was significantly greater in subjects exposed to the heavy load, when compared to the control subjects and low-load group (Tukey-Kramer multiple comparison). We further investigated subjects exposed to the heavy-loaded group for a fourth day. We found that dyspnea was significantly improved in the heavy-loaded subjects on this fourth day. Anxiety did not change significantly throughout the protocol.
These findings indicate that there is a threshold of inspiratory loading where normal subjects experience dyspnea, and that normal subjects are able to overcome this dyspnea. This compensation occurs over days and represents learning. T rees in the birch family, including alder, hazel, and birch, have wind-pollinated flowers that produce copious amounts of pollen and are a major cause of allergic rhinitis. How their pollen allergens cause asthma has been a mystery because pollen grains are too large to be inhaled into the airways where asthma occurs. Over the past 20 years, studies showed that episodes of pollen-induced asthma occurred during the flowering season, especially after periods of rainfall or thunderstorm. Immunologic studies revealed that abundant quantities of micronic particles occur in the outdoor air, especially after rainfall, and they are loaded with birch pollen allergens. How these respirable allergens were released into the air remained unknown. Recently, we have shown that for flowering grasses, pollen remains on the open anthers in the absence of wind or other disturbances. If wetted, pollen can rupture within minutes. 1 Fragmented cytoplasm is emitted through the pore region of the pollen grain. Drying winds release this cytoplasmic debris as a respirable allergen-loaded aerosol.
Identification of Birch Pollen
A similar mechanism results in the release of respirable allergen-loaded aerosol from birch flowers. However, birch pollen requires at least 3 h of wetting, and may germinate within the anther, prior to rupture. Other submicronic particles, such as orbicules and interorbicular structures, are also released from the anther surface; however, immunoblots show that they are not loaded with birch pollen allergens. Less than 5% of particles released in the size range of 30 to 800 nm are interorbicular structures. Particles of fragmented cytoplasm in the size range of 30 nm to 4.5 m are released from birch pollen grains and emitted into the air. The small size of these particles suggests that they can readily deposit in the lower airways.
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